Lemaitre Vascular Overview
- Year Founded
-
1983
- Status
-
Public
- Employees
-
655
- Stock Symbol
-
LMAT
- Investments
-
21
- Share Price
-
$73.61
- (As of Friday Closing)
Lemaitre Vascular General Information
Description
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Contact Information
Website
www.lemaitre.comCorporate Office
- 63 Second Avenue
- Burlington, MA 01803
- United States
Corporate Office
- 63 Second Avenue
- Burlington, MA 01803
- United States
Lemaitre Vascular Stock Performance
As of 20-Nov-2026, Lemaitre Vascular’s stock price is $73.61. Its current market cap is $1.68B with 22.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $73.61 | $74.80 | $73.44 - $118.01 | $1.68B | 22.9M | 278K | $2.78 |
Lemaitre Vascular Financials Summary
As of 30-Sep-2026, Lemaitre Vascular has a trailing 12-month revenue of $269M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,702,786 | 1,682,411 | 1,966,115 | 1,183,524 |
| Revenue | 269,356 | 249,602 | 219,863 | 193,484 |
| EBITDA | 97,814 | 90,786 | 66,688 | 48,990 |
| Net Income | 63,335 | 57,734 | 44,038 | 30,105 |
| Total Assets | 656,032 | 615,690 | 551,817 | 346,778 |
| Total Debt | 188,851 | 185,592 | 185,685 | 19,095 |
Lemaitre Vascular Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lemaitre Vascular Comparisons
Industry
Financing
Details
Lemaitre Vascular Competitors (20)
One of Lemaitre Vascular’s 20 competitors is Angiodynamics, a Corporation company based in Latham, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Angiodynamics | Corporation | Latham, NY | ||||
| Penumbra | Formerly VC-backed | Alameda, CA | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Teleflex | Corporation | Wayne, PA | ||||
| Inari Medical | Formerly VC-backed | Irvine, CA |
Lemaitre Vascular Patents
Lemaitre Vascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2012205353-A1 | Systems and methods for remote endarterectomy | Inactive | 14-Jan-2011 | ||
| CA-2824061-A1 | Systems and methods for remote endarterectomy | Inactive | 14-Jan-2011 | ||
| EP-2663247-A1 | Systems and methods for remote endarterectomy | Inactive | 14-Jan-2011 | ||
| WO-2012097292-A1 | Systems and methods for remote endarterectomy | Inactive | 14-Jan-2011 | ||
| JP-2013533772-A | Over-the-wire barbarotome | Inactive | 22-Jun-2010 | A61B17/320725 |
Lemaitre Vascular Signals
Lemaitre Vascular Investments & Acquisitions (21)
Lemaitre Vascular’s most recent deal was a Corporate Asset Purchase with B. Braun (Vascular Assets) for . The deal was made on 01-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| B. Braun (Vascular Assets) | 01-Oct-2026 | Corporate Asset Purchase | Buildings and Property | ||
| Prompt Serve | 14-Mar-2023 | Merger/Acquisition | Distributors (Healthcare) | ||
| Lombard Medical (Aorfix an Endovascular Stent Graft in Burlington, Vermont) | 01-Jan-2023 | Corporate Asset Purchase | Buildings and Property | ||
| Artegraft | 22-Jun-2020 | Merger/Acquisition | Therapeutic Devices | ||
| Admedus (Biologic Patch Business) | 11-Oct-2019 | Merger/Acquisition | Surgical Devices |
Lemaitre Vascular ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
31.94 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Lemaitre Vascular Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Artegraft | North Brunswick, NJ | 1993 |
Lemaitre Vascular FAQs
-
When was Lemaitre Vascular founded?
Lemaitre Vascular was founded in 1983.
-
Where is Lemaitre Vascular headquartered?
Lemaitre Vascular is headquartered in Burlington, MA.
-
What is the size of Lemaitre Vascular?
Lemaitre Vascular has 655 total employees.
-
What industry is Lemaitre Vascular in?
Lemaitre Vascular’s primary industry is Other Devices and Supplies.
-
Is Lemaitre Vascular a private or public company?
Lemaitre Vascular is a Public company.
-
What is Lemaitre Vascular’s stock symbol?
The ticker symbol for Lemaitre Vascular is LMAT.
-
What is the current stock price of Lemaitre Vascular?
As of 20-Nov-2026 the stock price of Lemaitre Vascular is $73.61.
-
What is the current market cap of Lemaitre Vascular?
The current market capitalization of Lemaitre Vascular is $1.68B.
-
What is Lemaitre Vascular’s current revenue?
The trailing twelve month revenue for Lemaitre Vascular is $269M.
-
Who are Lemaitre Vascular’s competitors?
Angiodynamics, Penumbra, Medtronic, Teleflex, and Inari Medical are some of the 20 competitors of Lemaitre Vascular.
-
What is Lemaitre Vascular’s annual earnings per share (EPS)?
Lemaitre Vascular’s EPS for 12 months was $2.78.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process